Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — December 2024

Genmab — December 2024

Planlagt Fastgjort Låst Flyttet Genmab
476 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #111

    Genmab leverer igen lovende data fra kræfthåb https://proinvestor.com/investornyt/1251772/genmab-leverer-igen-lovende-data-fra-kraefthab

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #112

      Tak til EL for alle nyhederne. Noget har ændret sig i aktien, gode nyheder uden fald !

      1 Reply Last reply
      0
      • K Offline
        K Offline
        KWC
        wrote on sidst redigeret af
        #113

        Lidt nyt fra konkurrenterne...

        1 Reply Last reply
        0
        • K Offline
          K Offline
          KWC
          wrote on sidst redigeret af
          #114

          https://www.biospace.com/drug-development/gsk-touts-42-survival-benefit-for-blenrep-in-multiple-myeloma-strengthening-bid-for-market-return?_gl=1*10oq5ns*_up*MQ.._gaMzc1NzEzMDI4LjE3MzM4NDI3NDA._ga_Q90M6MWJZ4MTczMzg0MjczOC4xLjAuMTczMzg0MjczOC4wLjAuMA..

          1 Reply Last reply
          0
          • K Offline
            K Offline
            KWC
            wrote on sidst redigeret af
            #115

            Link Preview Image
            Gilead/Arcellx’s Anito-Cel’s Differentiated Safety Profile Challenges J&J/Legend’s Carvykti

            Anito-cel has shown no signs of delayed neurotoxicity at around 9 months of follow-up, hinting at a safety profile that could set it apart from J&J and Legend’s Carvykti.

            favicon

            BioSpace (www.biospace.com)

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #116

              Evaluate Pharma forecast Darzalex 2025 $13.17bn https://x.com/NatRevDrugDisc/status/1866496363371941939

              1 Reply Last reply
              0
              • nohopeN Offline
                nohopeN Offline
                nohope
                wrote on sidst redigeret af
                #117

                En eller anden snottet provinsbank stiger 50 % og GEN falder.

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #118

                  Fristes til at sige at det var da lidt rart med konkurrence i MM

                  1 Reply Last reply
                  0
                  • D Offline
                    D Offline
                    deleted-user
                    wrote on sidst redigeret af
                    #119

                    jeg bliver altid så glad når Nohope skriver herinde. Det minder mig om, at der er plads til alle bidrag.

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #120

                      Ja lad endelig Jansen mærke et lille pust i nakken

                      1 Reply Last reply
                      0
                      • R Offline
                        R Offline
                        Raun
                        wrote on sidst redigeret af
                        #121

                        Genmab falder
                        stort set altid ovenpå ASH

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #122

                          there is just too much news on the JNJ antibodies to post all , but let's pick 1 - Vincent Rajkumar
                          @VincentRK
                          Just out: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma https://x.com/VincentRK/status/1866205101595189678

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #123

                            I remember the scepticism on maintenance and even more on smoldering therapie being debated here. maintenance is now common really and smoldering to come. we'll still benefit from it

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #124

                              Just a moment...

                              favicon

                              (www.nejm.org)

                              1 Reply Last reply
                              0
                              • L Offline
                                L Offline
                                lahn1
                                wrote on sidst redigeret af
                                #125

                                If I am not wrong Rajkumar use to be sceptic on Dara in general. Nice to see him turn.

                                1 Reply Last reply
                                0
                                • bongobobB Offline
                                  bongobobB Offline
                                  bongobob
                                  wrote on sidst redigeret af
                                  #126
                                  1. Nov 2019 solgte jeg 1 aktie til kurs 1600, købte en flaske whisky og gav resten til Helge. Det bliver ikke gentaget, men det er vel en festdag med After ASH ?
                                  1 Reply Last reply
                                  0
                                  • StockBullS Offline
                                    StockBullS Offline
                                    StockBull
                                    wrote on sidst redigeret af
                                    #127

                                    Genmab/Jan bør lytte nøje her og sikre, at de bliver first movers inden for de molekyler og proteiner og deres felt, som Huang også omtaler. Selvom klippet handler om Tesla, er pointen, at Genmab kan accelerere deres pipeline ved at anvende den samme teknologi, før konkurrenterne får overtaget. https://www.youtube.com/watch?v=5OOuSzcQNGg Huang snakker om et start op firma i starten ca. 30 sek inde 🙂

                                    1 Reply Last reply
                                    0
                                    • S Offline
                                      S Offline
                                      Sukkeralf
                                      wrote on sidst redigeret af
                                      #128

                                      Rina-S er ikke så langt bagefter Sutro, så full speed ahead……

                                      1 Reply Last reply
                                      0
                                      • S Offline
                                        S Offline
                                        Sukkeralf
                                        wrote on sidst redigeret af
                                        #129

                                        https://finance.yahoo.com/news/sutro-biopharma-announces-selected-dose-130000687.html

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #130

                                          data seemed to disappoint somewhat ... Sutro -16% yesterday...

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper